SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, ARGO, OSH
Date
3/26/2023 10:46:00 AM
(MENAFN- EIN Presswire) /ein news / -- NEW YORK, March 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Globus Medical, Inc. (NYSE: GMED)'s merger with NuVasive, Inc. Under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. If you are a Globus shareholder, click here to learn more about your rights and options .
Argo Group International Holdings, Ltd. (NYSE: ARGO)'s sale to Brookfield Reinsurance for $30.00 per share in cash. If you are an Argo shareholder, click here to learn more about your rights and options .
Oak Street Health, Inc. (NYSE: OSH)'s sale to CVS Health® for $39.00 per share. If you are an Oak Street shareholder, click here to learn more about your rights and options .
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email or .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
MENAFN26032023003118003196ID1105863160
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.